1. General
  2. Others

  3. Others

Dr. Reddy’s Laboratories launches Olanzapine Tablets

India Infoline News Service | Mumbai | April 25, 2012 08:36 IST

The ZYPREXA Tablets brand and generic had combined U.S. sales of approximately $3.28 billion for the most recent twelve months ending January 2012 according to IMS Health.

Dr. Reddy’s Laboratories announced today that it has launched Olanzapine Tablets (2.5 mg, 5 mg, 7.5 mg, 10 mg, 15 mg), a bioequivalent generic version of ZYPREXA Tablets in the US market on April 23, 2012 following the approval by the United States Food & Drug Administration (USFDA) of Dr. Reddy’s ANDA for Olanzapine Tablets.

Dr. Reddy’s Olanzapine Tablets in 20 mg had been awarded a 180-day period of marketing exclusivity in the U.S. on October 26, 2011 which was commercialized through a commercial, manufacture and supply agreement with Teva Pharmaceutical Industries Ltd.

The ZYPREXA Tablets brand and generic had combined U.S. sales of approximately $3.28 billion for the most recent twelve months ending January 2012 according to IMS Health.

Dr. Reddy’s Olanzapine Tablets in 2.5 mg, 5 mg, 7.5 mg, 10 mg, 15 mg and 20 mg strengths are available in 30 and 500 count bottles.

BSE 3,198.65 48.15 (1.53%)
NSE 3,199.45 48.20 (1.53%)

***Note: This is a BSE Chart









article
113103103819
Dr. Reddy’s Laboratories launches Olanzapine Tablets
Dr. Reddy’s Laboratories launches Olanzapine Tablets
The ZYPREXA Tablets brand and generic had combined U.S. sales of approximately $3.28 billion for the most recent twelve months ending January 2012 according to IMS Health.
http://www.indiainfoline.com/article/news-top-story/dr-reddy’s-laboratories-launches-olanzapine-tablets-113103103819_1.html
April 25, 2012 08:36 IST
http://content.indiainfoline.com/_media/iifl/img/article/old/full/1718993566_LS_drreddylab
Dr. Reddy’s Laboratories
Others
$rawVideoFileUrl$
$videoPlayerUrl$
 

 
 
Reports
News